- TheStreet.com•last month
AstraZeneca shares, meanwhile, were less-than-moved by the news.
- TheStreet.com•3 months ago
The negative investor sentiment for health care stocks in 2016 presented a particularly challenging environment to accomplish anything well. Each of these CEOs met the challenge and succeeded.
- Motley Fool•3 months ago
I should have bought shares of this biotech winner when I had the chance.
MDVN : Summary for Medivation, Inc. - Yahoo Finance
Medivation, Inc. (MDVN)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|